Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF

18 Apr 2024 18:11 CEST

Subscribe
Issuer

PHOTONIKE CAPITAL

Photonike Capital informs that the Board of Directors of Nucleus Life Ag convened the Ordinary Shareholders Assembly for the approval of the 2023 Financial Statements on 29 April 2024. The ultimate version, ratified by the external auditor Grant Thornton, gives a Net Profit of 596,897 CHF of which 523.978 CHF result of the insurance technical accounts.

The BoD also approved the BP 2024-2027 relating to the new product catalogue and the new distribution network presented at the FMA.

Year 2024 (CHF) 2025 (CHF) 2026 (CHF) 2027 (CHF) New premiums 133,675.000 167.625.000 191.650.000 191,650.000 Portfolio 218.406.484 367.591.936 532.600.830 692.816.350 Net P/L -360.520 433.388 1.255.722 1.975.931

Photonike Capital SA plans to increase the participation in the parent company NHII SCSp by 2025.

Source

PHOTONIKE CAPITAL

Provider

Euronext

Company Name

PHOTONIKE CAPITAL

ISIN

BE0948608451

Symbol

MLPHO

Market

Euronext Access

Attachments

  • Original Link
  • Permalink

Disclaimer

Photonike Capital SA published this content on 18 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 April 2024 16:16:17 UTC.